Discontinued — last reported Q2 '18
Note payable to DIRECTV
United Therapeutics Note payable to DIRECTV increased by 38.8% to $100.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 34.8%, from $154.50M to $100.80M. Over 5 years (FY 2020 to FY 2025), Note payable to DIRECTV shows an upward trend with a 12.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase suggests higher short-term debt reliance, while a decrease indicates the company is successfully paying down specific contractual obligations.
Detailed definition
This represents a short-term financial obligation owed to a specific corporate entity, categorized as a current liabilit...
Peer comparison
Similar to other 'Notes Payable' or 'Accounts Payable to Related Parties' found in the current liabilities section of peer balance sheets.
note_payable_directvHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.80M | $26.00M | $28.40M | $60.80M | $39.60M | $35.70M | $32.50M | $38.60M | $37.80M | $70.10M | $71.00M | $126.30M | $77.80M | $80.10M | $82.60M | $154.50M | $95.10M | $78.30M | $72.60M | $100.80M |
| QoQ Change | — | +4.8% | +9.2% | +114.1% | -34.9% | -9.8% | -9.0% | +18.8% | -2.1% | +85.4% | +1.3% | +77.9% | -38.4% | +3.0% | +3.1% | +87.0% | -38.4% | -17.7% | -7.3% | +38.8% |
| YoY Change | — | — | — | — | +59.7% | +37.3% | +14.4% | -36.5% | -4.5% | +96.4% | +118.5% | +227.2% | +105.8% | +14.3% | +16.3% | +22.3% | +22.2% | -2.2% | -12.1% | -34.8% |
Note payable to DIRECTV at Other Companies
Frequently Asked Questions
- What is United Therapeutics's note payable to directv?
- United Therapeutics (UTHR) reported note payable to directv of $100.80M in Q1 2026.
- How has United Therapeutics's note payable to directv changed year-over-year?
- United Therapeutics's note payable to directv decreased by 34.8% year-over-year, from $154.50M to $100.80M.
- What is the long-term trend for United Therapeutics's note payable to directv?
- Over 5 years (2020 to 2025), United Therapeutics's note payable to directv has grown at a 12.9% compound annual growth rate (CAGR), from $39.50M to $72.60M.
- What does note payable to directv mean?
- A short-term debt obligation owed to a specific business partner or related entity.